Drogmissbruk - ovanliga presentationer
Granskad av Dr Krishna Vakharia, MRCGPSenast uppdaterad av Dr Colin Tidy, MRCGPSenast uppdaterad 20 sept 2023
Uppfyller patientens redaktionella riktlinjer
- Ladda nerLadda ner
- Dela
- Language
- Diskussion
- Ask Patient
- Ljudversion
- Lägg till i föredragna källor på Google
Medicinska yrkesverksamma
Professionella referensartiklar är utformade för att användas av vårdpersonal. De är skrivna av brittiska läkare och baserade på forskningsbevis, brittiska och europeiska riktlinjer. Du kan hitta Narkotika för rekreation artikel mer användbar, eller en av våra andra hälsoartiklar.
Managing people with drug misuse problems in primary care involves not only treating patients who admit to their dependency but also recognising the signals in those who are reluctant to share this information. Not infrequently, you will also be approached by temporary patients attempting to obtain drugs by deception. GPs need to be alert to the possible significance of the following:
Temporary residents just passing through the area.
Patients with an overly familiar knowledge of medications, demanding analgesia for renal colic, sickle-cell crises, etc.
Patients giving evasive answers.
Signs of heavy smoking, strange smoke smells (cannabis, cocaine, heroin).
Acetone or glue smell on breath (solvent abuse).
Small pupils (opiates).
Needle tracks on arms, groin, legs, between toes; intravenous access difficult.
Abscesses and lymphadenopathy in nodes draining injection sites.
Signs of drug-associated illnesses (eg, endokardit, AIDS, kronisk viral hepatit).
Se även artiklarna om Assessment of Drug Dependence, Drug Misuse and Dependence, Opioid Misuse and Dependence, Crystal Methamphetamine Drug Abuse, Dual Diagnosis (Drug Abuse with Other Psychiatric Conditions), och Alcoholism and Alcohol Misuse - Recognition and Assessment.
Medical conditions presenting in drug misusers
Patients may present with a variety of medical conditions but the doctor may not be aware of the history of drug dependency. The following is a list of some of the possible scenarios:
Patient found unconscious - consider narcotics, barbiturates, solvents and benzodiazepine as well as alcohol (see also Opiate Poisoning).
Mental health:
Psykos - consider methylenedioxymethamphetamine (MDMA, or 'ecstasy'), lysergic acid diethylamide (LSD), amphetamine, anabolic steroids1 2 .
Agitation - common with benzodiazepines.
Respiratory:
Astma/dyspnoea - consider opiate-induced pulmonary oedema, asthma (may follow the smoking of heroin).
Reduced lung density, lung cysts and kronisk obstruktiv lungsjukdom (COPD) - may be related to cannabis use3 .
Lung abscess - may be a complication of right-sided staphylococcal endocarditis (common in intravenous drug users)4 .
Airway burns, pneumothorax, pneumomediastinum, 'crack lung' - these can all be complications of crack cocaine, due to its method of delivery5 .
Infektion:
Fever/pyrexia of unknown origin (PUO)/shivering - may be the only sign of endocarditis.
Shivering and headache - due to chemical/organism contamination of intravenous drug. If suspicious, outline risks and offer immediate referral to secondary care - may need blood cultures, and antibiotics - eg, gentamicin.
Hyperpyrexia - consider 'ecstasy'6 ; be wary of associated myoglobinuria, disseminated intravascular coagulation, renal failure.
Abscesses - if over an injection site, then often of mixed organisms.
Pneumoni - pneumococcus, haemophilus, tuberkulos, pneumocystis.
Symptoms suggestive of körtelfeber - may actually beHIVseroconversion illness.
Pain in a limb or back pain with fever - consider osteomyelit.
Cardiovascular:
Tachyarrhythmia - in young patients consider cocaine, amphetamines, endocarditis.
Hjärtinfarkt - may be associated with:
Stroke eller transitorisk ischemisk attack (TIA), spinal infarction - consider:
Myokardit, hypertrophic cardiomyopathy, dilated cardiomyopathy, aortic dissection - all noted in cocaine users7 .
Others:
Djup ventrombos - may result from injecting suspension of tablets into a groin; consider acute compartment syndrome; organise a creatinine kinase test.
Jaundice - hepatitis B, C, or D, anabolic steroids (cholestasis).
Severe förstoppning - unusual in a young patient, and may be sign of opiate abuse.
Cystitis - ketamine abuse can cause inflammation of the bladder lining, leading to frequency, urgency and nocturia (ketamine bladder syndrome).12
Severe sight impairment - may be secondary to fungal or bacterial endophthalmitis with or without endokardit, or talc or other particulate emboli.
Rhinitis - consider opiate withdrawal; other features may be colic/diarrhoea, lacrimation, dilated pupils, insomnia, piloerection, myalgia, low mood; (rhinitis may also be a sign of cocaine use).
Signs of sensory or motor neuropathy - consider solvent abuse.
Allmän ledning
The Department of Health produced 2017 UK guidelines on clinical management of drug misuse and dependence13 . They were prepared by an Independent Expert Working Group. The following chapters are covered within the guidance:
Essential elements of treatment provision.
Psychosocial components of treatment.
Pharmacological interventions.
Criminal justice system.
Health considerations.
Specific treatment situations and populations.
Advice on writing prescriptions.
Interactions.
Travelling abroad with controlled drugs.
Drugs and driving.
Exklusiva uppdateringar för vårdpersonal
Håll dig informerad med de senaste kliniska uppdateringarna, professionella insikter och evidensbaserad vägledning. Patient Pro-nyhetsbrevet sammanställer viktigt innehåll för vårdpersonal—levererat direkt till din inkorg.
Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.
Vidare läsning och referenser
- Drugs and Alcohol; Folkhälsomyndigheten England
- Murray-Thomas T, Jones ME, Patel D, et al; Risk of mortality (including sudden cardiac death) and major cardiovascular events in atypical and typical antipsychotic users: a study with the general practice research database. Cardiovasc Psychiatry Neurol. 2013;2013:247486. doi: 10.1155/2013/247486. Epub 2013 Dec 26.
- Alcohol and drug misuse - Prevention and treatment guidance; GOV.UK
- Glasner-Edwards S, Mooney LJ; Methamphetamine psychosis: epidemiology and management. CNS Drugs. 2014 Dec;28(12):1115-26. doi: 10.1007/s40263-014-0209-8.
- Piacentino D, Kotzalidis GD, Del Casale A, et al; Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review. Curr Neuropharmacol. 2015 Jan;13(1):101-21. doi: 10.2174/1570159X13666141210222725.
- Chatkin JM, Zabert G, Zabert I, et al; Lung Disease Associated With Marijuana Use. Arch Bronconeumol. 2017 Sep;53(9):510-515. doi: 10.1016/j.arbres.2017.03.019. Epub 2017 May 5.
- Gupta S, Banach DB, Chirch LM; Pulmonary artery intravascular abscess: A rare complication of incomplete infective endocarditis treatment in the setting of injection drug use. IDCases. 2018 Mar 30;12:88-91. doi: 10.1016/j.idcr.2018.03.019. eCollection 2018.
- Greenberg A, Stammers K, Moonsie I, et al; Image of the month: All puffed out - a case of crack lung. Clin Med (Lond). 2017 Apr;17(2):186-187. doi: 10.7861/clinmedicine.17-2-186.
- Onal O, Hasdiraz L, Oguzkaya F; A Rare Cause of Spontaneous Pneumomediastinum: Ecstasy Ingestion. Turk Thorac J. 2015 Oct;16(4):198-200. doi: 10.5152/ttd.2015.4466. Epub 2015 Apr 9.
- Havakuk O, Rezkalla SH, Kloner RA; The Cardiovascular Effects of Cocaine. J Am Coll Cardiol. 2017 Jul 4;70(1):101-113. doi: 10.1016/j.jacc.2017.05.014.
- Lee J, Sharma N, Kazi F, et al; Cannabis and Myocardial Infarction: Risk Factors and Pathogenetic Insights. Scifed J Cardiol. 2017;1(1). Epub 2017 Jul 22.
- Saricopur A, Dursunoglu D, Sanlialp M, et al; Subacute myocardial infarction due to long-term paint thinner and ecstasy abuse. Anatol J Cardiol. 2015 Feb;15(2):167-8. doi: 10.5152/akd.2015.5975. Epub 2015 Jan 21.
- Cheng YC, Ryan KA, Qadwai SA, et al; Cocaine Use and Risk of Ischemic Stroke in Young Adults. Stroke. 2016 Apr;47(4):918-22. doi: 10.1161/STROKEAHA.115.011417. Epub 2016 Mar 10.
- Muntan CD, Tuckler V; Cerebrovascular accident following MDMA ingestion. J Med Toxicol. 2006 Mar;2(1):16-8.
- Hong YL, Yee CH, Tam YH, et al; Management of complications of ketamine abuse: 10 years' experience in Hong Kong. Hong Kong Med J. 2018 Apr;24(2):175-181. doi: 10.12809/hkmj177086. Epub 2018 Apr 6.
- Drug misuse and dependence - UK guidelines on clinical management; GOV.UK, 2017
Om recensentenVisa fullständig biografi

Dr Krishna Vakharia, MRCGP
Medicinsk chef för hälsa, Optum UK
MBChB, MRCGP(2013), BMedSci (hons), DFSRH, DRCOG, PGDipDerm (Distn)
Dr Krishna Vakharia är en NHS-läkare. Hon är också en regelbunden examinator för den postgraduate Diplom i Praktisk Dermatologi vid Cardiff University samt Chief Medical Officer för hälsa på Optum UK.
Artikelhistorik
Artikeln finns också på Engelska, Tyska, Spanska, Franska, Italienska, Portugisiska, Hindi, Hebreiska, Arabiska, och Svenska.
Nästa granskning: 17 aug 2028
20 sept 2023 | Senaste versionen
Mer inom mental hälsa (psykiatri)
- Missbruk och förgiftning av amfetamin
- Psykiska hälsoproblem under graviditeten
- Utmattning inom primärvården
- Användning och missbruk av cannabis
- Barndomsdesintegrativ störning
- Gemenskapsvård
- Creutzfeldt-Jakobs sjukdom
- Missbruk av crystal methamphetamine
- Vanföreställningar och hallucinationer
- Drogmissbruk och beroende
- Emotionellt instabil personlighetsstörning
- Fabricerad eller framkallad sjukdom av vårdgivare
- Frontotemporal demens
- Incest
- Mini mentalt tillståndsundersökning
- Fattigdom och psykisk hälsa
- Självskada
- Sydenhams korea
- Tourette syndrom och andra ticsstörningar


